Laddar...
Tumor cell–intrinsic USP22 suppresses antitumor immunity in pancreatic cancer
Although immune checkpoint blockade (ICB) improves clinical outcome in several types of malignancies, pancreatic ductal adenocarcinoma (PDA) remains refractory to this therapy. Preclinical studies have demonstrated that the relative abundance of suppressive myeloid cells vs. cytotoxic T cells determ...
Sparad:
| I publikationen: | Cancer Immunol Res |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173406/ https://ncbi.nlm.nih.gov/pubmed/31871120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-19-0661 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|